Line 35: | Line 35: | ||
<source src="https://static.igem.org/mediawiki/2018/a/aa/T--Tongji_China--picture--Home_Page_Video.mp4" type="video/mp4"> | <source src="https://static.igem.org/mediawiki/2018/a/aa/T--Tongji_China--picture--Home_Page_Video.mp4" type="video/mp4"> | ||
</source></video></p></div> | </source></video></p></div> | ||
+ | <br><br><br> | ||
<div style="height: auto;margin-bottom: 15%;"> | <div style="height: auto;margin-bottom: 15%;"> | ||
<img src="https://static.igem.org/mediawiki/2018/5/5c/T--Tongji_China--picture-Home_page-1.png" width="50%;" style="float: left;" \> | <img src="https://static.igem.org/mediawiki/2018/5/5c/T--Tongji_China--picture-Home_page-1.png" width="50%;" style="float: left;" \> |
Revision as of 13:45, 16 October 2018
Welcome to
Tongji_China
Tongji_China
We focus our attention on
cancer therapy and T3SS to
create a new method to
present the promising individual
cancer antigen -“Neoantigen”.
cancer therapy and T3SS to
create a new method to
present the promising individual
cancer antigen -“Neoantigen”.
We use the bioinformatic method
to filter our item antigens and
use the T3SS in P.aeruginosa to deliver
them to the T cells through
oral intake.
to filter our item antigens and
use the T3SS in P.aeruginosa to deliver
them to the T cells through
oral intake.
We filter the antigens of interest.
Then we conduct the experiments
to prove that our system can work
efficiently and safely.
Then we conduct the experiments
to prove that our system can work
efficiently and safely.